Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their ...

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — ...

Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...

The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...

The new research and development site will combine research, process development and clinical trial manufacturing ...

Eli Lilly and Company and Purdue University are keeping their partnership alive beyond it’s previously expected years. In an ...

Eli Lilly and Co. and Purdue University have announced a $250 million investment over eight years to continue to accelerate ...

Eli Lilly and Co. and Purdue University on Friday announced an expanded collaboration agreement, with the Indianapolis ...

CVS said it will expand access to blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly CEO Dave Ricks urged the Trump administration to move ... In an earnings call May 1, Ricks said leaders of the Indianapolis pharmaceutical company support the government's goals to increase ...